Based on 0.35 T magnetic resonance-guided radiotherapy, what are the nonisotropic PTV margins required for conventional prostate radiotherapy?

被引:0
|
作者
Drabble, Joseph [1 ,2 ]
Das, Prantik [1 ]
George, Ben [1 ]
Camilleri, Philip [1 ]
Morris, Alex [1 ]
机构
[1] GenesisCare UK, Oncol, Oxford, England
[2] GenesisCare UK, 12 Hendred St, Oxford OX42ED, England
关键词
Magnetic resonance-guided radiation; therapy; PTV margins; Prostate cancer; Inter-and intrafractional motion; Cine-MRI; ADAPTIVE RADIOTHERAPY; MOTION; INTRAFRACTION; VARIABILITY; CORRECT; CANCER; RISK;
D O I
10.1016/j.meddos.2022.06.004
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This study aims to calculate planning target volume (PTV) margins for the prostate and seminal vesicles (SVs) from the use of magnetic resonance-guided radiation therapy (MRgRT). And whether nonisotropic PTV margins are beneficial for these structures. Organ motion is linked to the displacement of the prostate and SVs. From the use of MRgRT, the nearby organs at risk (OAR) can be visualized both inter- and intrafraction. This study looked to determine if there is a correlation between interfractional OAR changes and displacements to the prostate and SVs. Inter- and intrafractional data from 20 consecutive prostate cancer patients treated using extreme hypofractionated 0.35 T MRgRT indicated prostate and SV motion during treatment. Tracking points (TPs) on 2D sagittal cine-MRI enabled assessment of this intrafractional motion. To determine a correlation between rectal changes and target displacements, the rectal diameter (RD) changes were compared against the displacement differences (DDs) at the prostate and SVs. Eighty percent of patients required intrafractional imaging corrections during radiotherapy, including 16/100 fractions due to rectal volume increases and 24/100 fractions due to bladder volume increases. The frequency of >= 3 mm intrafraction displacement was considerably greater in TPs in the SV than in the prostate. A moderate positive correlation ( R 2 = 0.417) was shown between RD changes and DDs at the level of the prostate and SVs. The PTV margins required for 90% of the patient cohort for prostate and SVs are nonuniform in different directions, and the margin is larger for SVs. Organ motion contributed toward prostate and SV displacements and showed the importance of a robust bladder and rectal-filling protocol.Crown Copyright (c) 2022 Published by Elsevier Inc. on behalf of American Association of Medical Dosimetrists. All rights reserved.
引用
收藏
页码:334 / 341
页数:8
相关论文
共 50 条
  • [1] Robustness of radiomics features on 0.35 T magnetic resonance imaging for magnetic resonance-guided radiotherapy
    Michalet, Morgan
    Valenzuela, Gladis
    Debuire, Pierre
    Riou, Olivier
    Azria, David
    Nougaret, Stephanie
    Tardieu, Marion
    PHYSICS & IMAGING IN RADIATION ONCOLOGY, 2024, 31
  • [2] Dosimetric evaluation of respiratory gating on a 0.35-T magnetic resonance-guided radiotherapy linac
    Charters, John A.
    Abdulkadir, Yasin
    O'Connell, Dylan
    Yang, Yingli
    Lamb, James M.
    JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 2022, 23 (09):
  • [3] Deep learning-based dose prediction for magnetic resonance-guided prostate radiotherapy
    Fransson, Samuel
    Strand, Robin
    Tilly, David
    MEDICAL PHYSICS, 2024,
  • [4] What CTV-to-PTV margins are required for esophageal cancer radiotherapy?
    Boekhoff, M.
    Kotte, A.
    Mook, S.
    Borggreve, A.
    Goense, L.
    Heethuis, S.
    Van Rossum, P.
    Van Lier, A.
    Lagendijk, J.
    Meijer, G.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S519 - S520
  • [5] Reducing the Toxicity of Radiotherapy for Pancreatic Cancer With Magnetic Resonance-guided Radiotherapy
    Tchelebi, Leila T.
    Zaorsky, Nicholas G.
    Rosenberg, Jennifer C.
    Sharma, Navesh K.
    Tuanquin, Leonard C.
    Mackley, Heath B.
    Ellis, Rodney J.
    TOXICOLOGICAL SCIENCES, 2020, 175 (01) : 19 - 23
  • [6] Magnetic Resonance-Guided Adaptive Radiotherapy: A Solution to the Future
    Kupelian, Patrick
    Sonke, Jan-Jakob
    SEMINARS IN RADIATION ONCOLOGY, 2014, 24 (03) : 227 - 232
  • [7] The ViewRay System: Magnetic Resonance-Guided and Controlled Radiotherapy
    Mutic, Sasa
    Dempsey, James F.
    SEMINARS IN RADIATION ONCOLOGY, 2014, 24 (03) : 196 - 199
  • [8] Evaluation of PTV margins for CBCT-based prostate adaptive radiotherapy
    Dupont, F.
    Dechambre, D.
    Sterpin, E.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S1674 - S1674
  • [9] Online Magnetic Resonance-Guided Radiotherapy (oMRgRT) for Gynecological Cancers
    Portelance, Lorraine
    Corradini, Stefanie
    Erickson, Beth
    Lalondrelle, Susan
    Padgett, Kyle
    van der Leij, Femke
    van Lier, Astrid
    Jurgenliemk-Schulz, Ina
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [10] Magnetic resonance-guided radiotherapy (MRgRT) for patients with lung cancer
    Crockett, Cathryn
    Chuter, Robert
    Cobben, David
    Dubec, Michael
    Green, Olga
    Hackett, Sara
    McDonald, Fiona
    Robinson, Clifford
    Samson, Pamela
    Shiarli, Anna-Maria
    Straza, Michael
    Verhoeff, Joost
    Vlacich, Gregory
    Werner-Wasik, Maria
    Faivre-Finn, Corinne
    LUNG CANCER, 2021, 156 : S62 - S62